Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs

Clinical trial NCT04302662 · COMPLETED

Trial details

NCT number: NCT04302662
Sponsor: AzurRx SAS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis Cystic Fibrosis Gastrointestinal Disease Cystic Fibrosis of Pancreas

Start date: 2019-06-27
Primary completion: 2021-06-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.